Analysts have been eager to weigh in on the Healthcare sector with new ratings on DENTSPLY SIRONA (XRAY – Research Report), Turning Point Therapeutics (TPTX – Research Report) and IDEAYA Biosciences (IDYA – Research Report). DENTSPLY SIRONA (XRAY) In a report released yesterday, Jonathan Block from Stifel Nicolaus maintained a Hold rating on DENTSPLY SIRONA, with a price target of $40.00. The company's shares closed last Thursday at $37.85, close to its 52-week low of $35.00. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dentsply-sirona-xray-turning-point-therapeutics-tptx-and-ideaya-biosciences-idya?utm_source=advfn.com&utm_medium=referral
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
Von Mai 2022 bis Jun 2022 Click Here for more DENTSPLY SIRONA Charts.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
Von Jun 2021 bis Jun 2022 Click Here for more DENTSPLY SIRONA Charts.